Litigation Details for ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)

ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)

Docket	3:18-cv-10952	Date Filed	2018-06-22
Court	District Court, D. New Jersey	Date Terminated	2019-06-24
Cause	35:271 Patent Infringement	Assigned To	Freda L. Wolfson
Jury Demand	Plaintiff	Referred To	Tonianne J. Bongiovanni
Patents	7,229,636; 7,404,489; 7,879,349; 8,003,353; 8,940,714; 9,415,007
Link to Docket	External link to docket

Details for ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
2018-06-22				External link to document
2018-06-22	1		U.S. Patent No. 7,229,636, # 2 Exhibit B - U.S. Patent No. 7,404,489, # 3 Exhibit C - U.S. Patent No. …U.S. Patent No. 8,003,353, # 5 Exhibit E - U.S. Patent No. 8,940,714, # 6 Exhibit F - U.S. Patent No. … COMPLAINT for Patent Infringement against Lupin Atlantis Holdings SA ( Filing fee $ 400 receipt…2018 24 June 2019 3:18-cv-10952 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff	External link to document

Litigation summary and analysis for: ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)

Last updated: June 27, 2026

Litigation summary: ENDO Pharmaceuticals v. Lupin Atlantis Holdings (D.N.J. 3:18-cv-10952)

Executive summary: In ENDO Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA, 3:18-cv-10952 (D.N.J.), ENDO alleged that Lupin infringed and/or induced infringement of ENDO’s asserted U.S. patents tied to END0’s branded product(s) by filing an ANDA for a generic version and seeking FDA approval before patent expiration. The case is in the ANDA Paragraph IV framework typical of Hatch-Waxman disputes, with the litigation record centered on claim construction, infringement (direct/induced/contributory), invalidity (anticipation/obviousness), and potential settlement.

Note: A complete, citation-grade litigation summary requires docket-level specifics (patent numbers asserted, ANDA number, dates of claim construction and dispositive rulings, final judgment and any settlement). If those case-document details are not available in the provided record, a precise litigation summary cannot be produced.